Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)
47.50
-0.80 (-1.66%)
Sep 11, 2026, 4:08 PM HKT
HKG:6609 Revenue
Shanghai HeartCare Medical Technology Corporation had revenue of 291.03M CNY in the half year ending June 30, 2026, with 126.51% growth. This brings the company's revenue in the last twelve months to 513.79M, up 53.40% year-over-year. In the year 2025, Shanghai HeartCare Medical Technology Corporation had annual revenue of 408.29M with 46.92% growth.
Revenue (ttm)
513.79M CNY
Revenue Growth
+53.40%
P/S Ratio
3.03
Revenue / Employee
1.40M CNY
Employees
368
Market Cap
1.80B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 408.29M | 130.39M | 46.92% |
| Dec 31, 2024 | 277.90M | 45.56M | 19.61% |
| Dec 31, 2023 | 232.34M | 49.31M | 26.94% |
| Dec 31, 2022 | 183.03M | 92.94M | 103.17% |
| Dec 31, 2021 | 90.09M | 75.53M | 518.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Isotope & Radiation | 8.44B |
| Sisram Medical | 2.91B |
| AK Medical Holdings | 1.79B |
| MicroTech Medical (Hangzhou) | 957.05M |
| Peijia Medical | 905.10M |
| MicroPort NeuroScientific | 879.66M |
| Acotec Scientific Holdings | 721.55M |
| LEPU ScienTech Medical Technology (Shanghai) | 586.91M |